AKTS
AKTS
US01021M1045
Aktis Oncology, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 6.497.000 1.487.000
336.9%
Cost of Revenue -- --
--
Gross Profit -- --
--
81.181.000 53.537.000
51.6%
Operating Income -74.684.000 -52.050.000
43.5%
Pretax Income -63.731.000 -43.980.000
44.9%
Net Income Common Stockholders -63.731.000 -43.980.000
44.9%
-- --
--
-- --
--
ende